Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Synuclein-gamma (SNCG) in the Carcinogenesis of Uterine Papillary Serous Carcinoma

NCT01344837 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT01344837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01344837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Synuclein-gamma (SNCG) in the Carcinogenesis of Uterine Papillary Serous Carcinoma
Lead sponsor
Gynecologic Oncology Group
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
January 31, 2018
Enrollment
360 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial serous adenocarcinoma, stage i uterine corpus cancer, stage ii uterine corpus cancer, stage iii uterine corpus cancer, stage iv uterine corpus cancer